Charles Kevin Gorman Net Worth & Insider Trades

Charles Kevin Gorman - Chief Executive Officer, Neurocrine Biosciences Inc

As of February 9, 2022

What is Charles Kevin Gorman's Net Worth?

The current estimated net worth of Neurocrine Biosciences Inc's Chief Executive Officer, Charles Kevin Gorman, is estimated to be about $118.92M . Charles Kevin Gorman owns about 462,844 units of Neurocrine Biosciences Inc common stock. In the last 19 years at Neurocrine Biosciences Inc, Charles Kevin Gorman has sold an estimated value of $78.51M worth.

What is Charles Kevin Gorman's Past Insider Trading?

Charles Kevin Gorman's largest purchase order was 308,250 units , worth over $2.67M on January 12, 2021. Charles Kevin Gorman's largest sale order was 308,250 units , worth over $33.97M on January 12, 2021. In total, Charles Kevin Gorman has made about 60 transactions over 19 years of their time at Neurocrine Biosciences Inc. Charles Kevin Gorman usually trades in January, with the busiest year in 2017 and 2015. The most recent transaction was a sale order of 10,984 units , worth over $884.67K on February 9, 2022.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Charles Kevin Gorman's' Mailing Address?

  • Mailing address is 12790 el Camino Real San Diego CA 92130 CA

Neurocrine Biosciences Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Stock Awards
Other Compensation
Total
Kevin C. Gorman, Ph.D. 2018 $675,000 $425,250 $4,486,852 $2,998,832 $47,045 $8,632,979
Kevin C. Gorman, Ph.D. 2019 $725,000 $667,000 $6,000,525 $2,000,071 $58,230 $9,450,826
Kevin C. Gorman, Ph.D. 2020 $775,000 $542,500 $7,124,633 $5,375,188 $63,311 $13,880,632
Matthew C. Abernethy 2018 $420,000 $199,500 - $1,996,506 $69,741 $2,685,747
Matthew C. Abernethy 2019 $495,600 $284,970 $3,750,345 $1,250,035 $42,170 $5,823,120
Matthew C. Abernethy 2020 $545,200 $190,820 $2,999,869 $2,500,266 $45,021 $6,281,176
Eric Benevich 2018 $432,600 $205,485 $1,496,335 $1,499,417 $38,768 $3,672,605
Eric Benevich 2019 $467,200 $280,320 $3,750,345 $1,250,035 $45,547 $5,793,447
Eric Benevich 2020 $499,900 $199,960 $2,999,869 $3,000,257 $48,974 $6,748,960
Kyle W. Gano, Ph.D. 2018 $403,100 $191,473 $1,309,024 $2,656,575 $8,069 $4,568,241
Kyle W. Gano, Ph.D. 2019 $443,400 $266,040 $3,000,285 $1,000,076 $16,171 $4,725,972
Kyle W. Gano, Ph.D. 2020 $487,700 $207,273 $3,749,799 $2,750,210 $16,751 $7,211,733
Eiry W. Roberts, M.D. 2018 $490,700 $220,800 $2,863,700 $4,053,869 $671,554 $8,300,623
Eiry W. Roberts, M.D. 2019 $538,200 $309,465 $3,000,285 $1,000,076 $51,889 $4,899,915
Eiry W. Roberts, M.D. 2020 $575,900 $215,963 $2,624,855 $2,375,242 $56,073 $5,848,033
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/914475/000119312521111693/d87247ddef14a.htm

What are Neurocrine Biosciences Inc's Past Insider Trades?

Neurocrine Biosciences Inc's most recent insider trade came on August 16, 2022 by Malcolm Lloydsmith who sold 21,533 units worth $2.28M . In the last 19 years, insiders at Neurocrine Biosciences Inc have sold an estimated value of $353.47M and bought an estimated value of $60.61M worth of shares. Insider trading is most common in May, with the busiest year in 2017. The most active traders at the company are Dimitri Grigoriadis, Chief Research Officer,  Gary Lyons, Director,  and Haig Bozigian, Chief Development Officer .

NEUROCRINE BIOSCIENCES INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1